Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,100
Closed -$1M 97
2021
Q4
$1M Buy
13,100
+4,200
+47% +$335K 0.66% 49
2021
Q3
$668K Sell
8,900
-13,800
-61% -$1.05M 0.45% 70
2021
Q2
$1.76M Buy
22,700
+8,028
+55% +$597K 1.19% 32
2021
Q1
$1.08M Buy
+14,672
New +$1.08M 0.76% 42
2020
Q2
Sell
-2,934
Closed -$215K 103
2020
Q1
$215K Buy
+2,934
New +$231K 0.29% 78
2018
Q2
Sell
-36,994
Closed -$1.92M 108
2018
Q1
$1.92M Buy
36,994
+5,554
+18% +$300K 1.76% 18
2017
Q4
$1.69M Buy
+31,440
New +$1.74M 1.56% 20

Other funds holding MRK

Factorial Partners's MRK Position: Q1 2022 in Review

Factorial Partners sold out of Merck (MRK) in Q1 2022, closing a stake of 13,100 shares — an estimated $1M sold.

Factorial Partners first reported a position in MRK in Q4 2017 and held it in 7 quarters. The position peaked at $1.92M in Q1 2018. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Factorial Partners reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Factorial Partners sold 13,100 Merck shares in Q1 2022, an estimated $1M.
  • Factorial Partners first reported a position in Merck in Q4 2017 and held it in 7 quarters.
  • Factorial Partners's Merck position peaked at $1.92M in Q1 2018.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Factorial Partners's 13F filing for Q1 2022, filed 3 May 2022.